Jason Drew Smith - 31 Jan 2024 Form 4/A Insider Report for UroGen Pharma Ltd. (URGN)

Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
31 Jan 2024
Net transactions value
-$78,790
Form type
4/A
Filing time
05 Feb 2024, 21:16:49 UTC
Date Of Original Report
02 Feb 2024
Previous filing
08 Sep 2023
Next filing
12 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Sale $6,580 -417 -2.2% $15.78 18,824 01 Feb 2024 Direct F1, F2
transaction URGN Ordinary Shares Sale $19,693 -1,248 -5.9% $15.78 20,076 01 Feb 2024 Direct F1, F2
transaction URGN Ordinary Shares Sale $52,516 -3,328 -12% $15.78 23,414 01 Feb 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024.
F2 This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.